In CD4+ T cells of ITP patients, treatment with ONX-0914 for 72 h caused a significant decrease in CD25 expression, as compared to controls (p<0.0001, Figure 4B), while ML604440 had no significant effects. Here, CD4 is linked to autoimmune thrombocytopenic purpura.